← Back to Search

mHealth Application for Colorectal Cancer Screening (SUCCEED Trial)

N/A
Recruiting
Led By Maria Thomson, Ph.D.
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Summary

This trial studies how to increase colorectal cancer screening among African American men by involving barbers as Community Champions.

Who is the study for?
This trial is for adult men who identify as Black or African American, are due for colorectal cancer screening, and live or work in Petersburg, VA or nearby counties. It's not open to those who can't speak/read English or are already up-to-date with their screenings.Check my eligibility
What is being tested?
The study is testing a mobile health application designed to understand the needs and attitudes of Black men towards colorectal cancer screening and how community leaders like barbers can encourage screening participation.See study design
What are the potential side effects?
Since this trial involves an mHealth Application rather than a drug, traditional side effects aren't expected. However, participants may experience discomfort discussing personal health issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colorectal Screening Status
Secondary outcome measures
Determine feasibility of Mobile Health (mHealth) Application -Enrollment
Determine the feasibility of the mHealth Application - Sharing Content
Determine the feasibility of the mHealth Application- Clinic/ Screening Request
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tailored Screen to Save (S2S) contentExperimental Treatment1 Intervention
Content to be delivered using a combination of short video and text-based information optimized for delivery via Quick Response (QR) codes for smartphones.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
mHealth Application
2021
N/A
~160

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
702 Previous Clinical Trials
22,886,759 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,748 Previous Clinical Trials
40,959,371 Total Patients Enrolled
Maria Thomson, Ph.D.Principal InvestigatorVirginia Commonwealt University

Media Library

Tailored Screen to Save (S2S) content Clinical Trial Eligibility Overview. Trial Name: NCT05980182 — N/A
Colorectal Cancer Research Study Groups: Tailored Screen to Save (S2S) content
Colorectal Cancer Clinical Trial 2023: Tailored Screen to Save (S2S) content Highlights & Side Effects. Trial Name: NCT05980182 — N/A
Tailored Screen to Save (S2S) content 2023 Treatment Timeline for Medical Study. Trial Name: NCT05980182 — N/A
~6 spots leftby Oct 2024